JS Link, Inc.

JS Link, Inc., a genome-based biotechnology company focuses on the research and development of genome analysis services in South Korea and globally. Its next generation sequencing services include whole genome sequencing, De Novo sequencing, whole exome/targeted sequencing, transcriptome sequencing, epigenome sequencing, and single-cell RNA sequencing microarray services, such as DNA and microarray RNA analysis. Its portfolio also includes Fluidigm BioMark System, an automated PCR/qPCR system, TaqMan assay, and SNaPshot assay.

Additionally, it provides rare earth and permanent magnets. Founded in 2000 and headquartered in Seoul, South Korea, JS Link was formerly known as DNA Link, Inc. before rebranding in April 2025.